Atlas Trials

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Clinical trial NCT04914221 · COMPLETED

Trial details

NCT number
NCT04914221
Sponsor
Jeil Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Overactive Bladder(OAB)
Start date
2021-03-13
Primary completion
2021-05-26
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.